HUANG Shenshen, QIU Jiayong, MAO Yimin. Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease[J]. Journal of Rare Diseases, 2023, 2(1): 17-26. DOI: 10.12376/j.issn.2097-0501.2023.01.003
Citation: HUANG Shenshen, QIU Jiayong, MAO Yimin. Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease[J]. Journal of Rare Diseases, 2023, 2(1): 17-26. DOI: 10.12376/j.issn.2097-0501.2023.01.003

Chronic Thromboembolic Pulmonary Hypertension and ChronicThromboembolic Pulmonary Disease

  • Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary disease (CTEPD) are diseases that occur after acute pulmonary embolism resulting from residual and organized intra-pulmonary thrombus, with or without pulmonary hypertension(PH). The prognosis of these diseases has been dramatically improved with the continuous progress of treatment and the updated concept of the comprehensive treatment strategy. However, there is a lack of awareness of these diseases among medical practitioners, and a lack of epidemiological data in China, with unknown pathogenesis and non-specific clinical manifestations. Therefore, it is easy to misdiagnosis, underdiagnosis and delay diagnosis in clinical practice. To enhance the understanding of medical personnel, this paper summarizes the definition, epidemiology, pathology, pathogenesis, diagnosis and treatment of CTEPH and CTEPD.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return